Syndax Pharmaceuticals (SNDX) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.25
-1.03
-0.81
-0.58

Details

Expected EPS
-0.584043
Actual EPS
-0.78
Surprise EPS
-0.2
Surprise Percent
+33.55%

Description

Syndax Pharmaceuticals (SNDX) has reported earnings of -0.78 per share for Q1 2026.

0 Comments

Share your thoughts